Cardiovascular and renal risk

Quality prescribing strategy for type 2 diabetes mellitus: a guide for improvement
Scottish Government Effective Prescribing & Therapeutics Division
Polypharmacy icon of two pills

Consider ASCVD, CKD and HF risk

Algorithm for the management of type 2 diabetes

Case study 3: Diabetes, SGLT-2is and managing adverse effects

Case study 4 : Diabetes, polypharmacy and chronic kidney disease

Case study 2: Polypharmacy and symptomatic diabetes